PMV Pharma, located in Cranbury, NJ, is a pioneering biopharmaceutical company focused on harnessing the power of p53 to combat cancer. With over 40 years of experience, PMV takes a unique approach to restoring mutated p53 proteins, aiming to correct their structure and restore their tumor-suppressing function.
The company's pipeline includes the innovative drug rezatapopt, currently undergoing clinical trials for various types of cancer. PMV Pharma is dedicated to advancing cancer research and providing hope for patients with p53 mutations through their cutting-edge scientific approach.
Generated from the website